NEW RESEARCH—Model-based clustering of a federated international cohort produces a data-driven subclassification of ANCA-associated #vasculitis that exhibits higher predictive value than current approaches for key outcomes thelancet.com/journals/lanrh… FAIRVASC Vasculitis_Lund

🌟Join our Glomerular Diseases Fellowship Hopkins Nephrology for July 2024 - June 2025!🌟 🔬 Dive into rare diseases, research & patient care 📚 Comprehensive training in nephrology 🌎 ACGME residency and nephrology fellowship required 🌐 J1/H1B visas welcome 📄 Application details 👇

📄 hopkinsmedicine.org/nephrology/edu… 📧 Send CV, 3 recs, & personal statement to [email protected]. 🔍 Queries? Contact Dr. John Sperati ([email protected]) or Dr. Duvuru Geetha ([email protected]). #NephrologyFellowship #GlomerularDiseases #MedEd

Inhibition of complement factor C5a or C5aR for cholesterol crystal embolism–related vascular thrombosis with microvascular injury and its consequences doi: 10.1016/j.kint.2024.07.020 Universität München DZHK Germany Uniklinik RWTH AC Hans-Joachim Anders Ohio State Nephrology #AKI #diabetes

Long-term outcome of kidney function in patients with ANCA-associated vasculitis 🔓doi.org/10.1093/ndt/gf…

Already downloaded :)

Hamburg news: Our research from teams CKLab plus Ulf Panzer, and collaborators identify pathogenic T cells in ANCA-associated vasculitis as a target for treatment. HCKH_Hamburg UKE Hamburg Universität Hamburg pubmed.ncbi.nlm.nih.gov/39300109/

Thank you so much Tiffany Caza for an excellent talk about membranous nephropathy (and artwork! 👩‍🎨🎨) GlomCon

Excellent vasculitis sessions at #ASNKidneyWeek American Society of Nephrology To immerse yourself in all forms of #vasculitis to learn and work collaboratively across disciplines come to Melbourne - Feb 2026 - for the 22nd Int Vasculitis Workshop. Register your interest at vasculitis-melbourne2026.com

djmsix TILDA Irish Nephrology Society St Vincent's University Hospital (SVUH) The Full Part 1 akdh.org/issue/S2949-81…

Just published in Kidney International - The impact of PLEX and GC on early kidney function changes in AAV. (kidney-international.org/article/S0085-…) This analysis provides another important piece of the “PLEX puzzle”. Many thanks to my co-authors, the PIs and especially to Andreas Kronbichler and David Jayne.

Our multi-continental study on differences in phenotypes, treatments and outcomes of AAV started as a survey to see how induction therapy has changed during the pandemic (Jan 2020-Jun 2020). But we did not see any. Follow-up investigations revealed differences in GFR at baseline

Join KDIGO Guideline Education Meetings (GEMS) #Nephpearls 🗓️ January 13-14, 2025 ⏰ Check your Time Zone (Europe and Asia; USA and Europe) REGISTER 👉 gems-gd.org/home#overview 📌 A new program offering virtual education on the latest KDIGO Guidelines and evidence-based

The effects of #plasmaexchange and #glucocorticoids on early kidney function among patients with #ANCA-associated #vasculitis in the PEXIVAS trial doi.org/10.1016/j.kint… #OpenAccess #glomerulonephritis #ESKD

What an exciting news Liz Prof Liz B 🇬🇧🇮🇱🇺🇦🇵🇸!!! Many many congratulations. Lots of love and good wishes 🥰♥️

Come join us for #IVW2026 in Australia, and in the vibrant city of Melbourne! February offers perfect summer weather - ideal for beach trips and exploring the city’s famous laneways. Join the Mailing List (vasculitis-melbourne2026.com) to keep up to date!

👏🏼👏🏼👏🏼

ANCA-negative pauci-immune GN is reported to occur in up to 30% of cases; in Europe, it has a prevalence of 1-5% of cases. Our multi-centre series reported the largest cohort of 132 cases and was just published in KIReports kireports.org/article/S2468-… Baseline char. are given!

NEWS 🚨 Iptacopan receives FDA approval for C3 glomerulopathy Treatment with iptacopant resulted in clinically meaningful proteinuria reduction, which was seen as early as 14 days and sustained at 12 months globenewswire.com/news-release/2…